Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM (1997) <br />Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>280</b>: 710<br /><br />Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW, Jr., Davis L, Vargas HM (1996) <br />Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>277</b>: 728<br /><br />Shutske GM, Tomer JD, Kapples KJ, Hrib NJ, Jurcak JG, Bores GM, Huger FP, Petko W, Smith CP (1992) <br />Aminopyridine carbamic acid esters: synthesis and potential as acetylcholinesterase inhibitors and acetylcholine releasers<br /><i>J Pharm Sci</i> <b>81</b>: 380<br /><br />